Published in Br J Cancer on July 01, 2000
Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma | NCT00868192
Predicting response to bevacizumab in ovarian cancer: a panel of potential biomarkers informing treatment selection. Clin Cancer Res (2013) 2.45
Expression of vascular endothelial growth factor, hypoxia inducible factor 1alpha, and carbonic anhydrase IX in human tumours. J Clin Pathol (2004) 2.36
CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. Am J Pathol (2002) 1.85
Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. Am J Pathol (2002) 1.70
Thrombospondin-1 inhibits VEGF levels in the ovary directly by binding and internalization via the low density lipoprotein receptor-related protein-1 (LRP-1). J Cell Physiol (2007) 1.35
Risk factors for GI adverse events in a phase III randomized trial of bevacizumab in first-line therapy of advanced ovarian cancer: A Gynecologic Oncology Group Study. J Clin Oncol (2014) 1.18
Clinical significance of vascular endothelial growth factor expression and neovascularization in colorectal carcinoma. World J Gastroenterol (2003) 1.17
Absolute lymphocyte count is associated with survival in ovarian cancer independent of tumor-infiltrating lymphocytes. J Transl Med (2012) 1.16
Antiangiogenic drugs in ovarian cancer. Br J Cancer (2008) 1.06
Angiotensin II type 1 receptor expression in ovarian cancer and its correlation with tumour angiogenesis and patient survival. Br J Cancer (2006) 1.05
A current review of targeted therapeutics for ovarian cancer. J Oncol (2010) 1.02
Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer. Chin J Cancer Res (2012) 1.01
Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation. Mol Ther (2012) 0.99
Angiogenic role for glycodelin in tumorigenesis. Proc Natl Acad Sci U S A (2001) 0.99
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clin Cancer Res (2010) 0.99
Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World J Gastroenterol (2007) 0.97
Role of vascular endothelial growth factor inhibitors in the treatment of gynecologic malignancies. J Gynecol Oncol (2010) 0.94
Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation. Mol Cancer (2011) 0.93
CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells. J Immunol (2014) 0.87
Profile of bevacizumab in the treatment of platinum-resistant ovarian cancer: current perspectives. Int J Womens Health (2016) 0.85
Bevacizumab in the treatment of ovarian cancer. Biologics (2011) 0.85
Inhibition of epidermoid carcinoma A431 cell growth and angiogenesis in nude mice by early and late treatment with a novel dextran derivative. Br J Cancer (2003) 0.84
Correlation of the expression of vascular endothelial growth factor and its receptors with microvessel density in ovarian cancer. Oncol Lett (2013) 0.84
Bevacizumab and ovarian cancer. Ther Adv Med Oncol (2013) 0.83
Predictive and prognostic protein biomarkers in epithelial ovarian cancer: recommendation for future studies. Cancers (Basel) (2010) 0.83
Vascular endothelial growth factor (VEGF) polymorphism and increased risk of epithelial ovarian cancer. J Cancer Res Clin Oncol (2014) 0.83
Prognostic Relevance of the Expression of CA IX, GLUT-1, and VEGF in Ovarian Epithelial Cancers. Korean J Pathol (2012) 0.82
Targeted agents in epithelial ovarian cancer: review on emerging therapies and future developments. Ecancermedicalscience (2016) 0.81
Antivascular therapy for epithelial ovarian cancer. J Oncol (2009) 0.80
Utility of vascular endothelial growth factor inhibitors in the treatment of ovarian cancer: from concept to application. J Oncol (2011) 0.79
Impaired CXCL4 expression in tumor-associated macrophages (TAMs) of ovarian cancers arising in endometriosis. Cancer Biol Ther (2012) 0.79
Targeting the insulin growth factor and the vascular endothelial growth factor pathways in ovarian cancer. Mol Cancer Ther (2012) 0.79
Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance. Iran J Cancer Prev (2015) 0.78
The relationship of the angiogenesis regulators VEGF-A, VEGF-R1 and VEGF-R2 to p53 status and prognostic factors in epithelial ovarian carcinoma in FIGO-stages I-II. Int J Oncol (2016) 0.78
Ovarian cancer: emerging molecular-targeted therapies. Biologics (2012) 0.77
Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget (2016) 0.77
Therapeutic advances in women's cancers. Front Biosci (Schol Ed) (2011) 0.76
Relevant molecular markers and targets. Gynecol Oncol (2006) 0.75
VEGF Expression to Support Targeted Therapy in Ovarian Surface Epithelial Neoplasms. J Clin Diagn Res (2017) 0.75
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature (1993) 15.70
Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (1983) 15.43
What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41
Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science (1989) 8.10
The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (1992) 7.49
Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun (1989) 7.39
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (1994) 5.19
Vascular endothelial growth factor: molecular and biological aspects. Curr Top Microbiol Immunol (1999) 2.79
How is blood vessel growth regulated in normal and neoplastic tissue? G.H.A. Clowes memorial Award lecture. Cancer Res (1986) 2.69
Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma. J Natl Cancer Inst (1995) 2.44
The role of vascular endothelial growth factor in pathological angiogenesis. Breast Cancer Res Treat (1995) 2.39
Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer (1997) 2.20
Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Cancer (1999) 2.17
Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol (1995) 2.02
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels. Br J Cancer (1997) 1.72
Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res (1994) 1.59
Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms. Lab Invest (1996) 1.50
Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol (1995) 1.47
Tumoral vascularity as a prognostic factor in cancer. Important Adv Oncol (1996) 1.35
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. Cancer Lett (1997) 1.13
Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet Gynecol (1998) 1.13
Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors. Lab Invest (1997) 1.01
Vascular endothelial growth factor levels in ovarian cyst fluid correlate with malignancy. Clin Cancer Res (1999) 0.99
The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer. Int J Gynecol Pathol (1997) 0.94
Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer (1998) 0.92
Mucin carbohydrate antigens (T, Tn, and sialyl-Tn) in human ovarian carcinomas: relationship with histopathology and prognosis. Hum Pathol (1997) 0.89
Expression of vascular endothelial growth factor related to 72-kilodalton metalloproteinase immunostaining in patients with serous ovarian tumors. Cancer (1999) 0.88
VEGF, VEGFR-1, VEGFR-2, microvessel density and endothelial cell proliferation in tumours of the ovary. Int J Cancer (1999) 0.88
Vascular endothelial growth factor expression as a prognostic index in serous ovarian cystoadenocarcinomas: relationship with MIB1 immunostaining. Gynecol Oncol (1999) 0.87
Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary. Br J Cancer (1998) 0.86
A pair of related genes with antagonistic roles in mediating flowering signals. Science (1999) 7.51
Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. Am J Pathol (1979) 5.94
Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy. Magn Reson Med (1990) 4.88
Genetic and molecular analysis of an allelic series of cop1 mutants suggests functional roles for the multiple protein domains. Plant Cell (1994) 4.07
Expression profiling reveals hepsin overexpression in prostate cancer. Cancer Res (2001) 3.45
FASCIATA genes for chromatin assembly factor-1 in arabidopsis maintain the cellular organization of apical meristems. Cell (2001) 2.56
Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet (1994) 2.36
Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension (2000) 2.35
GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. Neuron (1998) 2.29
Stimulated formation of adenosine 3',5'-cyclic phosphate in cerebral cortex: synergism between electrical activity and biogenic amines. Proc Natl Acad Sci U S A (1970) 2.19
Validation study of the in vitro micronucleus test in a Chinese hamster lung cell line (CHL/IU). Mutagenesis (1999) 2.16
A radioisotopic method for measuring the formation of adenosine 3',5'-cyclic monophosphate in incubated slices of brain. J Neurochem (1969) 2.13
EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron (2001) 2.08
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. N Engl J Med (1980) 2.07
Keratosis follicularis squamosa (Dohi): a follicular keratotic disorder well known in Japan. Br J Dermatol (2001) 2.01
Revised classification system for inherited epidermolysis bullosa: Report of the Second International Consensus Meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol (2000) 1.97
Eccrine porocarcinoma and Bowen's disease arising in a seborrhoeic keratosis. Clin Exp Dermatol (2006) 1.95
Ultrastructure of pulmonary mast cells in patients with fibrotic lung disorders. Lab Invest (1979) 1.94
Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Oncogene (1998) 1.92
Demonstration of mother-to-infant transmission of hepatitis B virus by means of polymerase chain reaction. Lancet (1989) 1.90
Artemin, a novel member of the GDNF ligand family, supports peripheral and central neurons and signals through the GFRalpha3-RET receptor complex. Neuron (1998) 1.89
New quantitative method to determine protein concentration and cell number in aqueous in vivo. Jpn J Ophthalmol (1988) 1.85
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol (2001) 1.82
Amyotrophic lateral sclerosis: T2 shortening in motor cortex at MR imaging. Radiology (1993) 1.81
Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions. AJR Am J Roentgenol (1998) 1.80
Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care (1999) 1.78
5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males. Lancet (1992) 1.77
The role of intraalveolar fibrosis in the process of pulmonary structural remodeling in patients with diffuse alveolar damage. Am J Pathol (1987) 1.76
Reliability and validity of a questionnaire for assessment of energy expenditure and physical activity in epidemiological studies. J Epidemiol (1998) 1.76
Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg (2002) 1.75
Effects of sugar on vegetative development and floral transition in Arabidopsis. Plant Physiol (2001) 1.75
Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region. Euro Surveill (2015) 1.73
ABCA3 is a lamellar body membrane protein in human lung alveolar type II cells. FEBS Lett (2001) 1.71
Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues. Oncogene (1998) 1.70
Development of a screening questionnaire for tobacco/nicotine dependence according to ICD-10, DSM-III-R, and DSM-IV. Addict Behav (1999) 1.68
The extracellular domain of BPAG2 localizes to anchoring filaments and its carboxyl terminus extends to the lamina densa of normal human epidermal basement membrane. J Invest Dermatol (1997) 1.63
N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry (1996) 1.63
Resection of hepatic and pulmonary metastases in patients with colorectal carcinoma. Cancer (1998) 1.62
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Accuracy of screening for gastric cancer using serum pepsinogen concentrations. Gut (1999) 1.60
Cancer of the gastrointestinal tract among Japanese and white immigrants in Los Angeles County. J Natl Cancer Inst (1987) 1.59
Effective hepatic artery chemoembolization for advanced hepatocellular carcinoma with extensive tumour thrombus through the hepatic vein. J Gastroenterol Hepatol (1999) 1.59
Scanning transmission X-ray, laser scanning, and transmission electron microscopy mapping of the exopolymeric matrix of microbial biofilms. Appl Environ Microbiol (2003) 1.58
Overtime, psychosocial working conditions, and occurrence of non-insulin dependent diabetes mellitus in Japanese men. J Epidemiol Community Health (1999) 1.57
Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007. Vaccine (2009) 1.55
Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis. Am J Pathol (2001) 1.54
Effect of motion imagery to counter rest-induced suppression of F-wave as a measure of anterior horn cell excitability. Clin Neurophysiol (2008) 1.53
Benefits and limits of hepatic resection for gastric metastases. Am J Surg (2001) 1.52
Case-control studies of prostate cancer in blacks and whites in southern California. J Natl Cancer Inst (1987) 1.51
An intrinsic velocity-independent criterion for superfluid turbulence. Nature (2003) 1.51
Strand-specific nucleotide composition bias in echinoderm and vertebrate mitochondrial genomes. J Mol Evol (1991) 1.50
Successful treatment of severe recalcitrant erosive oral lichen planus with topical tacrolimus. J Eur Acad Dermatol Venereol (2006) 1.50
T cells bearing gamma/delta T cell receptor and their expression of activation antigen in peripheral blood from patients with Sjögren's syndrome. Clin Exp Rheumatol (1992) 1.50
Kluyveromyces lactis killer toxin inhibits adenylate cyclase of sensitive yeast cells. Nature (1983) 1.50
A case of linear IgA bullous dermatosis with IgA anti-type VII collagen autoantibodies. Br J Dermatol (1996) 1.48
Structure of alveolar epithelial cells in patients with fibrotic lung disorders. Lab Invest (1982) 1.48
Histones have high affinity for the glomerular basement membrane. Relevance for immune complex formation in lupus nephritis. J Exp Med (1989) 1.48
Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery (1998) 1.47
Late onset diabetes mellitus in patients with hereditary aceruloplasminemia. Intern Med (1996) 1.47
Diffusion-weighted MR imaging with single-shot echo-planar imaging in the upper abdomen: preliminary clinical experience in 61 patients. Abdom Imaging (1999) 1.46
Hepatic resection for colorectal metastases: analysis of prognostic factors. Dis Colon Rectum (1999) 1.46
Spontaneously perforated pyometra presenting as diffuse peritonitis in older females at nursing homes. J Am Geriatr Soc (2001) 1.46
Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer (1998) 1.46
Aggressive surgical resection for hepatic metastases involving the inferior vena cava. Am J Surg (1999) 1.44
Angiotensin II binding activity in cultured porcine arterial endothelial cells. Biochem Pharmacol (1994) 1.44
Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin Exp Res (2001) 1.44
Comparison of diffusion- and T2-weighted MRI for the early detection of cerebral ischemia and reperfusion in rats. Magn Reson Med (1991) 1.44
A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. Mol Immunol (2000) 1.44
Kikuchi's disease and the skin: case report and review of the literature. Br J Dermatol (2001) 1.43
Effect of alpha-phenyl-N-tert-butyl nitrone (PBN) on fetal cerebral energy metabolism during intrauterine ischemia and reperfusion in rats. Pediatr Res (2000) 1.43
Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis? J Gastroenterol (1999) 1.43
Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease. Am Rev Respir Dis (1981) 1.42
Functional divergence of the TFL1-like gene family in Arabidopsis revealed by characterization of a novel homologue. Genes Cells (2001) 1.42
Self-organized control of bipedal locomotion by neural oscillators in unpredictable environment. Biol Cybern (1991) 1.41
Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol (1999) 1.41
Thiodiglycolic acid as a possible causative agent of fixed drug eruption provoked only after continuous administration of S-carboxymethyl-L-cysteine: case report and review of reported cases. Br J Dermatol (2005) 1.41
The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients. J Gastroenterol (1999) 1.40
Preserved musical abilities following right temporal lobectomy. J Neurosurg (1996) 1.39
Augmented enhancement of in vitro production of inflammatory cytokines in peripheral blood mononuclear cells in patients undergoing simultaneous resection of the liver and gastrointestinal tract. Crit Care Med (1999) 1.39
HLA antigens in patients with variant angina in Japan. Int J Cardiol (1999) 1.39
Combined peripheral and central chemoembolization of liver tumors. Experience with lipiodol-doxorubicin and gelatin sponge (L-TAE). Cancer (1988) 1.39
Ganglioneuroma: computed tomography and magnetic resonance features. Br J Radiol (1996) 1.38
Asymptomatic pulmonary hypertension complicated with antiphospholipid syndrome case. Intern Med (1996) 1.38
Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg (1999) 1.37
High spectral resolution lidar system with atomic blocking filters for measuring atmospheric parameters. Appl Opt (1983) 1.37
Light scattering study on motile spermatozoa. IEEE Trans Biomed Eng (1977) 1.37
Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem Biophys Res Commun (1990) 1.36
Disruption of ATM in p53-null cells causes multiple functional abnormalities in cellular response to ionizing radiation. Oncogene (1999) 1.35
Systematic isolation of peptide signal molecules regulating development in hydra: LWamide and PW families. Proc Natl Acad Sci U S A (1997) 1.32
Characterization of a novel killer toxin encoded by a double-stranded linear DNA plasmid of Kluyveromyces lactis. Eur J Biochem (1984) 1.32
Nonsurgical management of ruptured pseudoaneurysm in patients with hepatobiliary pancreatic diseases. Am J Gastroenterol (2001) 1.32
Brain structural changes as vulnerability factors and acquired signs of post-earthquake stress. Mol Psychiatry (2012) 1.31
Mammographic density and the risk of breast cancer in Japanese women. Br J Cancer (2005) 1.30
Refractoriness to mammary tumorigenesis in parous rats: is it caused by persistent changes in the hormonal environment or permanent biochemical alterations in the mammary epithelia? Carcinogenesis (1995) 1.29
Crystal structure of nitric oxide reductase from denitrifying fungus Fusarium oxysporum. Nat Struct Biol (1997) 1.29
Effects of corticotropin-releasing factor on food intake and brown adipose tissue thermogenesis in rats. Am J Physiol (1988) 1.29
Expression of a subset of the Arabidopsis Cys(2)/His(2)-type zinc-finger protein gene family under water stress. Gene (2000) 1.28
Purification and characterization of a novel beta-agarase from Vibrio sp. AP-2. Eur J Biochem (1990) 1.27
Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol (2000) 1.26